The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab plus chemotherapy or apatinib in the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma: A double-cohort phase II study.
 
Guoxin Ren
No Relationships to Disclose
 
Houyu Ju
No Relationships to Disclose
 
Rong-hui Xia
No Relationships to Disclose
 
Jingzhou Hu
No Relationships to Disclose
 
Yunteng Wu
No Relationships to Disclose
 
Chenping Zhang
No Relationships to Disclose
 
Xu Ding
No Relationships to Disclose
 
Heming Wu
No Relationships to Disclose
 
Shizhou Zhang
No Relationships to Disclose
 
Yue He
No Relationships to Disclose